TLC C-53: Began a 24-patient Phase I/II trial

The Liposome Company Inc. (LIPO) Princeton, N.J. Product: TLC C-53, liposomal prostaglandin E1 Indication: Treatment of adult respiratory distress syndrome Status: Began a 24-patient Phase I/II trial ...